ArticlePloS one2025
Hazediff: A training-free diffusion-based image dehazing method with pixel-level feature injection.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the current environmental context, significant emissions generated by industrial and transportation activities, coupled with an unreasonable energy structure, have resulted in recurrent haze phenomena. This consequently leads to degraded image contrast and reduced resolution in captured images, significantly hindering subsequent mid- and high-level visual tasks. These technical challenges have positioned image dehazing as a pivotal research frontier in computer vision. Nevertheless, current image dehazing approaches exhibit notable limitations. Deep learning-based methodologies demand extensive paired hazy-clean training datasets, the acquisition of which remains particularly challenging. Furthermore, synthetically generated data frequently exhibit marked disparities from authentic scenarios, thereby limiting model generalizability. Despite diffusion-based approaches demonstrating superior image reconstruction performance, their data-driven implementations face comparable limitations. To overcome these challenges, we propose HazeDiff: a training-free dehazing method based on the Diffusion model. This method provides a novel perspective for image dehazing research. Unlike existing approaches, it eliminates the need for hard-to-get paired training data, reducing computational costs while enhancing generalization. This not only reduces computational costs but also improves the generalization ability and stability on different datasets. Ultimately, it ensures that the dehazing restoration results are more reliable and effective. The Pixel-Level Feature Inject (PFI) we proposed is implemented through the self-attention layer. It integrates the pixel-level feature representation of the reference image into the initial noise of the dehazing image, effectively guiding the diffusion process to achieve the dehazing effect. As a supplement, the Structure Retention Model (SRM) incorporated in Cross-attention performs dynamic feature enhancement through adaptive attention re-weighting. This ensures the retention of key structural features during the restoration process while reducing detail loss. We have conducted comprehensive experiments on both real-world and synthetic datasets.Experimental results demonstrate that HazeDiff surpasses state-of-the-art dehazing methods, achieving higher scores on both no-reference (e.g., NIQE) and full-reference (e.g., PSNR) evaluation metrics. It shows stronger generalization ability and practicality. It can restore high-quality images with natural visual features and clear structural content from low-quality hazy images.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.